{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:19:46Z","timestamp":1791335986496,"version":"4.3.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.chest.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T02:31:07Z","timestamp":1453343467000},"page":"1482-1493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"149","author":[{"given":"Alice","family":"Huertas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bordenave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ly","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Thuillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morane","family":"Le Hiress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Jovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Guignabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.chest.2016.01.004_bib1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"issue":"25\u00a0suppl","key":"10.1016\/j.chest.2016.01.004_bib2","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.chest.2016.01.004_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.chest.2016.01.004_bib4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1183\/09031936.00004414","article-title":"Validation of two predictive models for\u00a0survival in pulmonary arterial hypertension","volume":"46","author":"Sitbon","year":"2015","journal-title":"Eur Respir J"},{"issue":"25\u00a0suppl","key":"10.1016\/j.chest.2016.01.004_bib5","doi-asserted-by":"crossref","first-page":"D13","DOI":"10.1016\/j.jacc.2013.10.035","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"62","author":"Soubrier","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.chest.2016.01.004_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circ Res"},{"issue":"1 suppl","key":"10.1016\/j.chest.2016.01.004_bib7","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.chest.2016.01.004_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1183\/09031936.03.00038903","article-title":"Inflammation in pulmonary arterial hypertension","volume":"22","author":"Dorfm\u00fcller","year":"2003","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2016.01.004_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.201105-0927OC","article-title":"Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension","volume":"185","author":"Perros","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2016.01.004_bib10","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1183\/09031936.00046612","article-title":"Pathobiology of pulmonary arterial hypertension and right ventricular failure","volume":"40","author":"Voelkel","year":"2012","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.chest.2016.01.004_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1164\/rccm.201408-1509OC","article-title":"Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension","volume":"192","author":"Soon","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2016.01.004_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1164\/rccm.201201-0164OC","article-title":"Modern age pathology of pulmonary arterial hypertension","volume":"186","author":"Stacher","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2016.01.004_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T\u00a0cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat Immunol"},{"issue":"49","key":"10.1016\/j.chest.2016.01.004_bib14","doi-asserted-by":"crossref","first-page":"19446","DOI":"10.1073\/pnas.0706832104","article-title":"CD4+CD25+Foxp3+ regulatory T\u00a0cells induce alternative activation of human monocytes\/macrophages","volume":"104","author":"Tiemessen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.chest.2016.01.004_bib15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/annrheumdis-2011-200195","article-title":"IgG from patients with pulmonary arterial hypertension and\/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction","volume":"71","author":"Bussone","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.chest.2016.01.004_bib16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1183\/09031936.00181410","article-title":"Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma","volume":"39","author":"Dib","year":"2012","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2016.01.004_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/thx.2004.029082","article-title":"Anti-endothelial cell antibodies in\u00a0idiopathic and systemic sclerosis associated pulmonary arterial hypertension","volume":"60","author":"Tamby","year":"2005","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.chest.2016.01.004_bib18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1164\/rccm.200707-1015OC","article-title":"Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension","volume":"177","author":"Terrier","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2016.01.004_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1183\/09031936.00164209","article-title":"Prevalence of anti-endothelial cell antibodies in idiopathic pulmonary arterial hypertension","volume":"35","author":"Arends","year":"2010","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2016.01.004_bib20","first-page":"286","article-title":"High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension","volume":"23","author":"Karmochkine","year":"1996","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.chest.2016.01.004_bib21","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/CIRCULATIONAHA.113.004555","article-title":"Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay","volume":"129","author":"Huertas","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.chest.2016.01.004_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.110.236927","article-title":"Regulatory T\u00a0cells limit vascular endothelial injury and prevent pulmonary hypertension","volume":"109","author":"Tamosiuniene","year":"2011","journal-title":"Circ Res"},{"issue":"200","key":"10.1016\/j.chest.2016.01.004_bib23","doi-asserted-by":"crossref","first-page":"200ra117","DOI":"10.1126\/scitranslmed.3006674","article-title":"Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension","volume":"5","author":"Tian","year":"2013","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.chest.2016.01.004_bib24","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1183\/09031936.00159911","article-title":"Leptin and regulatory T-lymphocytes in\u00a0idiopathic pulmonary arterial hypertension","volume":"40","author":"Huertas","year":"2012","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2016.01.004_bib25","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2016.01.004_bib26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.104.492488","article-title":"Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice","volume":"112","author":"Song","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.chest.2016.01.004_bib27","first-page":"263","article-title":"Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension","volume":"211","author":"Sawada","year":"2014","journal-title":"J\u00a0Exp\u00a0Med"},{"issue":"7","key":"10.1016\/j.chest.2016.01.004_bib28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.107.736801","article-title":"Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension","volume":"118","author":"Hong","year":"2008","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.chest.2016.01.004_bib29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1164\/rccm.201202-0309OC","article-title":"A\u00a0critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents","volume":"186","author":"Tu","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2016.01.004_bib30","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.4049\/jimmunol.179.11.7593","article-title":"Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity","volume":"179","author":"Pallandre","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.chest.2016.01.004_bib31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000111548","article-title":"Increased regulatory and decreased CD8+ cytotoxic T\u00a0cells in the blood of patients with idiopathic pulmonary arterial hypertension","volume":"75","author":"Ulrich","year":"2008","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.chest.2016.01.004_bib32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T\u00a0cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.chest.2016.01.004_bib33","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1073\/pnas.0509484103","article-title":"Single-cell analysis of normal and FOXP3-mutant human T\u00a0cells: FOXP3 expression without regulatory T\u00a0cell development","volume":"103","author":"Gavin","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.chest.2016.01.004_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4+ T\u00a0cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.chest.2016.01.004_bib35","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1183\/09031936.00193014","article-title":"Leptin\u00a0signalling system as a target for pulmonary arterial hypertension therapy","volume":"45","author":"Huertas","year":"2015","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2016.01.004_bib36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1183\/09031936.00151313","article-title":"Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension","volume":"43","author":"Cracowski","year":"2014","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2016.01.004_bib37","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1183\/09031936.00164713","article-title":"Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension","volume":"4","author":"Heresi","year":"2014","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2016.01.004_bib38","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","article-title":"Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension","volume":"122","author":"Soon","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.chest.2016.01.004_bib39","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2016.01.004_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1183\/09031936.00094706","article-title":"Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension","volume":"29","author":"Perros","year":"2007","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2016.01.004_bib41","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.chest.2016.01.004_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0002-9343(92)90238-7","article-title":"Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku","volume":"93","author":"Isern","year":"1992","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.chest.2016.01.004_bib43","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.14-1678","article-title":"T-helper 17 cell polarization in pulmonary arterial hypertension","volume":"147","author":"Hautefort","year":"2015","journal-title":"Chest"},{"issue":"Pt 1","key":"10.1016\/j.chest.2016.01.004_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BJ20051578","article-title":"Intracellular signalling pathways activated by leptin","volume":"393","author":"Fr\u00fchbeck","year":"2006","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.chest.2016.01.004_bib45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1350","article-title":"The weight of leptin in immunity","volume":"4","author":"La Cava","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.chest.2016.01.004_bib46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.smim.2011.04.003","article-title":"Making sense of regulatory T\u00a0cell suppressive function","volume":"23","author":"Shalev","year":"2011","journal-title":"Semin Immunol"},{"issue":"3","key":"10.1016\/j.chest.2016.01.004_bib47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","article-title":"TGF-beta: a master of all T\u00a0cell trades","volume":"134","author":"Li","year":"2008","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.chest.2016.01.004_bib48","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.4049\/jimmunol.0901112","article-title":"Cutting edge: OX40 agonists can drive regulatory T\u00a0cell expansion if the cytokine milieu is right","volume":"183","author":"Ruby","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"2 Pt B","key":"10.1016\/j.chest.2016.01.004_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molimm.2015.06.015","article-title":"Cyclin-dependent kinase 5 represses Foxp3 gene expression and Treg\u00a0development through specific phosphorylation of Stat3 at Serine 727","volume":"67","author":"Lam","year":"2015","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.chest.2016.01.004_bib50","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1183\/09031936.00183008","article-title":"Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension","volume":"34","author":"Dewachter","year":"2009","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2016.01.004_bib51","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000024324","article-title":"Athymic nude rats develop severe pulmonary hypertension following monocrotaline administration","volume":"121","author":"Miyata","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"issue":"12","key":"10.1016\/j.chest.2016.01.004_bib52","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1164\/rccm.200608-1189OC","article-title":"Absence of T\u00a0cells confers increased pulmonary arterial hypertension and vascular remodeling","volume":"175","author":"Taraseviciene-Stewart","year":"2007","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921600461X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921600461X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T09:55:22Z","timestamp":1531130122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236921600461X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S001236921600461X"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2016.01.004","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}